Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Crispr Therapeutics AG (CRSP)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Crispr Therapeutics's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
54.36 +2.82    +5.47%
15:59:59 - Closed. Currency in USD ( Disclaimer )
After Hours
54.50
+0.14
+0.26%
17:51:14 - Real-time Data
Type:  Equity
Market:  United States
ISIN:  CH0334081137 
  • Volume: 1,367,471
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 51.69 - 54.87
Crispr Therapeutics 54.36 +2.82 +5.47%
RankUsernameTotalClosedWinningWin %Chg. %
1Bryan_Ali99888.89+266.88%
2René Kucher222100+70.11%
3glen w odonnell222100+64.19%
4vittorio marinello33266.67+60.45%
5Aftab Nadeem111100+57.85%
6Ta Ha111100+54.65%
7Cris Funk55360+52.1%
8Daria Miglio111100+48.81%
9EMANUELE FINO222100+47.15%
10Francesco Troiani22150+44.27%
11Nicole Adams111100+42.08%
12Thierry Bolle111100+41.63%
13Gregory Doest22150+41.52%
14Eric Sorensen111100+40.87%
15Santos Reivax22150+37.61%
16Terrence Gadson111100+36.81%
17Fredrik Myllymäki111100+35.1%
18Crystal Golden111100+34.86%
19Aleksi Jurvanen111100+34.51%
20Andrew Minton222100+33.81%
21José Prince111100+32.52%
22Jeff Baxter111100+32.01%
23Carmelo Sapienza22150+31.26%
24Henrik33266.67+31.06%
25alex averbuch111100+30.56%
26RemyAlex Johansen111100+28.61%
27Fab And111100+28.5%
28HalmuratDNA111100+28.14%
29Fong PH111100+24.39%
30Jonas Binder111100+23.88%
31Matt Rombough111100+23.6%
32Witold Płóciniczak111100+23.42%
33Andre Silveira111100+23.11%
34jean intilia1000+22.14%
35maor Ye1000+21.73%
36Sven Christian111100+21.12%
37alik flish111100+18.11%
38Benjamin Slavik111100+17.47%
39Wai Lun Tsang444100+15.3%
40Bradley Engel111100+15.18%
41Cole Anon1000+14.89%
42Eugene Wu111100+12.3%
43Mark Warbanski111100+11.66%
44Jisup Shin111100+11.36%
45David Faizulaev111100+11.28%
46Enrique Lucas111100+10.96%
47Sathya Narayanan1000+10.78%
48vbg99111100+10.21%
49Ricky Carter111100+9.49%
50Soren Ena111100+9.42%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CRSP Comments

Write your thoughts about Crispr Therapeutics AG
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Billy Bilnaad
Billy Bilnaad Mar 01, 2022 10:43AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Nice price
min zhang
min zhang Jan 28, 2022 12:19PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The earning date posted here is wrong. Its 2/16/22. So miss leading
Warr Muzz
WarrMuzz Dec 17, 2021 9:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
wow... it's bucking the trend
Nuno Da Silva
Nuno Da Silva Dec 09, 2021 3:52AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
another cathy wood investment ¡ Good luck ...enjoy the elevator
Marco Castañeda
Marco Castañeda Nov 23, 2021 12:27PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
CRISPR Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to CTX110™ for the Treatment of Relapsed or Refractory CD19+ B-cell malignanciesZUG, Switzerland and CAMBRIDGE, Mass., Nov. 22, 2021 (GLOBE NEWSWIRE) http://ir.crisprtx.com/news-releases/news-release-details/crispr-therapeutics-announces-fda-regenerative-medicine-advanced
jason xx
jason xx Nov 18, 2021 2:28PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Amazing how fast this went from breakthrough life changing technology to garbage in about a month
jason xx
jason xx Nov 18, 2021 2:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
One paragraph of good news and this goes back to 160 in a day after the sheep pile in. Not just this ticker but any of them.
Benjamin Kim
Benjamin Kim Nov 06, 2021 1:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Added 1100 shares
sharad sharma
sharad sharma Nov 06, 2021 1:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
now u must be regretting
Benjamin Kim
Benjamin Kim Nov 06, 2021 1:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
nope I'm long!
Lucky Man
Lucky Man Oct 29, 2021 1:53PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
keep tanking this stock what a hopeless
Abdulla Amiri
Abdulla Amiri Oct 18, 2021 2:47PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Ouch
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email